| scholarly article | Q13442814 |
| P50 | author | Shigeru Kohno | Q104013331 |
| Hiroshi Mukae | Q114454285 | ||
| Jun-Ichi Kadota | Q114561026 | ||
| P2093 | author name string | Heiichiro Udono | |
| Katsuyuki Yui | |||
| Kiri Honma | |||
| Masakatsu Ueda | |||
| Yuko Kawabata | |||
| P2860 | cites work | The crystal structure of C-terminal merozoite surface protein 1 at 1.8 A resolution, a highly protective malaria vaccine candidate | Q27618095 |
| Protective Immunity produced by the Injection of X-irradiated Sporozoites of Plasmodium berghei | Q28259011 | ||
| A recombinant 15-kilodalton carboxyl-terminal fragment of Plasmodium yoelii yoelii 17XL merozoite surface protein 1 induces a protective immune response in mice. | Q33599911 | ||
| Protection of mice against Plasmodium yoelii sporozoite challenge with P. yoelii merozoite surface protein 1 DNA vaccines | Q33757015 | ||
| Detection of individual mouse splenic T cells producing IFN-gamma and IL-5 using the enzyme-linked immunospot (ELISPOT) assay. | Q33842374 | ||
| Immunization with a recombinant C-terminal fragment of Plasmodium yoelii merozoite surface protein 1 protects mice against homologous but not heterologous P. yoelii sporozoite challenge | Q35557454 | ||
| A single fragment of a malaria merozoite surface protein remains on the parasite during red cell invasion and is the target of invasion-inhibiting antibodies. | Q36352078 | ||
| CD4+ cytolytic T cell clone confers protection against murine malaria | Q36353821 | ||
| Allelic forms of gp195, a major blood-stage antigen of Plasmodium falciparum, are expressed in liver stages | Q36354328 | ||
| In vivo cytotoxic T lymphocyte elicitation by mycobacterial heat shock protein 70 fusion proteins maps to a discrete domain and is CD4(+) T cell independent | Q36375719 | ||
| Recombinant Mycobacterium bovis bacillus Calmette-Guérin secreting merozoite surface protein 1 (MSP1) induces protection against rodent malaria parasite infection depending on MSP1-stimulated interferon gamma and parasite-specific antibodies | Q36404193 | ||
| Evidence for a 6.5-day minimum exoerythrocytic cycle for Plasmodium falciparum in humans and confirmation that immunization with a synthetic peptide representative of a region of the circumsporozoite protein retards infection | Q37175987 | ||
| T cell responses to pre-erythrocytic stages of malaria: role in protection and vaccine development against pre-erythrocytic stages | Q40898245 | ||
| Gamma interferon, CD8+ T cells and antibodies required for immunity to malaria sporozoites | Q41386252 | ||
| The large difference in infectivity for mice of Plasmodium berghei and Plasmodium yoelii sporozoites cannot be correlated with their ability to enter into hepatocytes | Q44173638 | ||
| Genetic control of immunity to Plasmodium yoelii sporozoites | Q44979627 | ||
| Expression of the precursor of the major merozoite surface antigens during the hepatic stage of malaria | Q46961537 | ||
| Comparison of humoral immune responses elicited by DNA and protein vaccines based on merozoite surface protein-1 from Plasmodium yoelii, a rodent malaria parasite. | Q47838036 | ||
| Absolute requirement for an active immune response involving B cells and Th cells in immunity to Plasmodium yoelii passively acquired with antibodies to the 19-kDa carboxyl-terminal fragment of merozoite surface protein-1. | Q47848374 | ||
| Heat shock proteins come of age: primitive functions acquire new roles in an adaptive world | Q47877336 | ||
| Plasmodium vivax: exoerythrocytic schizonts recognized by monoclonal antibodies against blood-stage schizonts | Q47912851 | ||
| Immunization against blood-stage rodent malaria using purified parasite antigens | Q47996405 | ||
| Genetic regulation of protective immune response in congenic strains of mice vaccinated with a subunit malaria vaccine. | Q48030282 | ||
| Details of an isolation method for hepatic lymphocytes in mice | Q68053183 | ||
| Isolation and flow cytometric analysis of the free lymphomyeloid cells present in murine liver | Q68536782 | ||
| Generation of cytotoxic T lymphocytes by MHC class I ligands fused to heat shock cognate protein 70 | Q74582187 | ||
| P433 | issue | 11 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | Plasmodium yoelii | Q12065970 |
| P304 | page(s) | 6075-6082 | |
| P577 | publication date | 2002-11-01 | |
| P1433 | published in | Infection and Immunity | Q6029193 |
| P1476 | title | Merozoite surface protein 1-specific immune response is protective against exoerythrocytic forms of Plasmodium yoelii | |
| P478 | volume | 70 |
| Q43986541 | Adenovectors induce functional antibodies capable of potent inhibition of blood stage malaria parasite growth |
| Q34334187 | Analysis of antibodies directed against merozoite surface protein 1 of the human malaria parasite Plasmodium falciparum |
| Q37761208 | Blood-stage malaria vaccines - recent progress and future challenges |
| Q30555356 | CD8+ T cells specific for a malaria cytoplasmic antigen form clusters around infected hepatocytes and are protective at the liver stage of infection |
| Q35771456 | Combining liver- and blood-stage malaria viral-vectored vaccines: investigating mechanisms of CD8+ T cell interference |
| Q41985489 | Evaluation of recombinant Plasmodium knowlesi merozoite surface protein-1(33) for detection of human malaria |
| Q48008497 | Gamma interferon levels and antibody production induced by two PvMSP-1 recombinant polypeptides are associated with protective immunity against P.vivax in Aotus monkeys |
| Q36882512 | Humoral and cellular immunity to Plasmodium falciparum merozoite surface protein 1 and protection from infection with blood-stage parasites |
| Q48031825 | Immune responses in mice induced by prime-boost schemes of the Plasmodium falciparum apical membrane antigen 1 (PfAMA1)-based DNA, protein and recombinant modified vaccinia Ankara vaccines |
| Q35792444 | Initiation of the Immune Response by Extracellular Hsp72: Chaperokine Activity of Hsp72 |
| Q34290768 | New candidate vaccines against blood-stage Plasmodium falciparum malaria: prime-boost immunization regimens incorporating human and simian adenoviral vectors and poxviral vectors expressing an optimized antigen based on merozoite surface protein 1 |
| Q50095531 | Non-specific CD8+ T cells and dendritic cells/macrophages participate in CD8+ T cell-mediated cluster formation against malaria liver-stage infection. |
| Q35623459 | Phase Ia clinical evaluation of the Plasmodium falciparum blood-stage antigen MSP1 in ChAd63 and MVA vaccine vectors |
| Q28731894 | Phase Ia clinical evaluation of the safety and immunogenicity of the Plasmodium falciparum blood-stage antigen AMA1 in ChAd63 and MVA vaccine vectors |
| Q47964836 | Production of IFN-γ by CD4(+) T cells in response to malaria antigens is IL-2 dependent |
| Q35094826 | Protection of Malian children from clinical malaria is associated with recognition of multiple antigens |
| Q37146236 | Recombinant viral vaccines expressing merozoite surface protein-1 induce antibody- and T cell-mediated multistage protection against malaria |
| Q36043731 | Recombinant viral-vectored vaccines expressing Plasmodium chabaudi AS apical membrane antigen 1: mechanisms of vaccine-induced blood-stage protection |
| Q37608653 | Strain-specific immunity induced by immunization with pre-erythrocytic stages of Plasmodium chabaudi |
| Q36114395 | Tailoring subunit vaccine immunogenicity: maximizing antibody and T cell responses by using combinations of adenovirus, poxvirus and protein-adjuvant vaccines against Plasmodium falciparum MSP1. |
| Q35177864 | The requirement for potent adjuvants to enhance the immunogenicity and protective efficacy of protein vaccines can be overcome by prior immunization with a recombinant adenovirus |
| Q45875096 | ΔE1 and high-capacity adenoviral vectors expressing full-length codon-optimized merozoite surface protein 1 for vaccination against Plasmodium falciparum |
Search more.